LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
Sponsor: University of Sydney
Trial Details
| Condition | Arrhythmias, Cardiac, Breast Cancer, Prostatic Cancer, Brain Cancer, Kidney Cancer, Head and Neck Cancer, Liver Cancer, Pancreatic Cancer, Spinal Neoplasm |
| Status | Recruiting |
| Participants | 300 |
| Est. Completion | 31 Jan 2028 |
| Last Updated | 19 May 2026 |
Primary Outcome
Accuracy of markerless tracking
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Will receive radiation therapy for brain, breast, head and neck, kidney, liver, pancreas, prostate, spine cancer treatment or cardiac arrhythmia treatment at a participating centre. * Will receive CT planning, and a cone beam CT scan for at least one fraction of radiation therapy. * Will receive intrafraction x-ray imaging for the liver, pancreas, prostate, spine cancer treatment or cardiac arrhythmia treatment. As intrafraction imaging is not common standard of care for brain, breast, head and neck and kidney cancer treatments there is no requirement to have intrafraction x-ray imaging data for these anatomical sites. * Provides written informed consent. Exclusion Criteria: * Less than 18 years of age
Trial Sites
🇦🇺 Australian Sites (4)
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service